AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 SEP 2 - (NewsRx.com & NewsRx.net) -- Hologic, Inc., (HOLX), a provider of women's diagnostic imaging systems and state-of-the-art digital imaging systems, announced its results for the quarter ended June 26, 2004.
Third quarter fiscal 2004 revenues totaled $59,225,000, a 13% increase when compared to revenues of $52,332,000 in the third quarter of fiscal 2003. For the third quarter of fiscal 2004, Hologic reported net income of $3,325,000, or $0.15 per diluted share, compared with net income of $1,019,000 or $0.05 per diluted share, in the third quarter of fiscal 2003.
The improvement in earnings reflects the increase in revenues, led by the continued shift in product sales to the higher margin digital mammography systems (Selenia). Included in the results was $741,000 the company incurred in due diligence and related expenses in connection with the analysis and negotiation of a potential acquisition. At quarter-end, the company had decided not to pursue this potential acquisition further and accordingly expensed all acquisition-related costs.
For the 9 months ended June 26, 2004, revenues totaled $164,756,000 compared to revenues of $151,631,000 in the 9 months ended June 28, 2003. For the 9 months ended June 26, 2004, Hologic recognized net income of $6,954,000, or $0.33 per diluted share, compared with net income of $282,000, or $0.01 per diluted share, for the comparable 9-month period in fiscal 2003.
During the third quarter, Hologic installed and recognized as revenue 37 Selenia ...
Source: HighBeam Research, Imaging/diagnostics company reports increased revenues in Q3.